MIKHALITSKAYA et al.1900
BIOCHEMISTRY (Moscow) Vol. 89 No. 11 2024
evidence for its colocalization with neurotransmitters
and neuropeptides, J. Compar. Neurol., 489, 275-292,
https://doi.org/10.1002/cne.20598.
45. Gosselin, R. D., Varela, C., Banisadr,G., Mechighel, P.,
Rostene, W., Kitabgi, P., and Melik-Parsadaniantz, S.
(2005) Constitutive expression of CCR2 chemokine
receptor and inhibition by MCP‐1/CCL2 of GABA‐
induced currents in spinal cord neurons, J. Neuro-
chem., 95, 1023-1034, https://doi.org/10.1111/j.1471-
4159.2005.03431.x.
46. Galimberti, D., Fenoglio,C., Lovati, C., Venturelli, E.,
Guidi, I., Corrà, B., Scalabrini, D., Clerici, F., Mari-
ani, C., Bresolin, N., and Scarpini, E. (2006) Serum
MCP-1 levels are increased in mild cognitive impair-
ment and mild Alzheimer’s disease, Neurobiol. Aging,
27, 1763-1768, https://doi.org/10.1016/j.neurobiolaging.
2005.10.007.
47. Mahad, D. J., and Ransohoff, R. M. (2003) The role
of MCP-1 (CCL2) and CCR2 in multiple sclerosis and
experimental autoimmune encephalomyelitis (EAE),
Semin. Immunol., 15, 23-32, https://doi.org/10.1016/
S1044-5323(02)00125-2.
48. Minami, M., and Satoh, M. (2003) Chemokines and
their receptors in the brain: pathophysiological roles
in ischemic brain injury, Life Sci., 74, 321-327, https://
doi.org/10.1016/j.lfs.2003.09.019.
49. Wu,D., Zhou,J., Bi,H., Li,L., Gao,W., Huang,M., Ad-
cock, I.M., Barnes, P.J., and Yao,X. (2014) CCL11 as a
potential diagnostic marker for asthma? J.Asthma, 51,
847-854, https://doi.org/10.3109/02770903.2014.917659.
50. Baruch, K., Ron-Harel, N., Gal, H., Deczkowska, A.,
Shifrut,E., Ndifon,W., Mirlas-Neisberg,N., Cardon,M.,
Vaknin, I., Cahalon, L., Berkutzki, T., Mattson, M. P.,
Gomez-Pinilla, F., Friedman, N., and Schwartz, M.
(2013) CNS-specific immunity at the choroid plexus
shifts toward destructive Th2 inflammation in brain
aging, Proc. Natl. Acad. Sci. USA, 110, 2264-2269,
https://doi.org/10.1073/pnas.1211270110.
51. Erickson, M. A., Morofuji, Y., Owen, J. B., and Banks,
W. A. (2014) Rapid transport of CCL11 across the
blood-brain barrier: regional variation and impor-
tance of blood cells, J.Pharmacol. Exp. Ther., 349, 497-
507, https://doi.org/10.1124/jpet.114.213074.
52. Krathwohl, M.D., and Kaiser, J.L. (2004) Chemokines
promote quiescence and survival of human neu-
ral progenitor cells, Stem Cells, 22, 109-118, https://
doi.org/10.1634/stemcells.22-1-109.
53. Parajuli,B., Horiuchi,H., Mizuno,T., Takeuchi,H., and
Suzumura,A. (2015) CCL11 enhances excitotoxic neu-
ronal death by producing reactive oxygen species in
microglia, Glia, 63, 2274-2284, https://doi.org/10.1002/
glia.22892.
54. Cunha, G. R., Asevedo, E., Mansur, R. B., Zugman,A.,
Pan, P. M., Gadelha, A., Belangero, S. I., Rizzo, L. B.,
Coelho, R., Stertz, L., Cogo-Moreira,H., Grassi-Olivei-
ra,R., Teixeira, A.L., Kauer-Sant’Anna, M., Mari, J. J.,
Miguel, E. C., Bressan, R. A., and Brietzke, E. (2016)
Inflammation, neurotrophism and oxidative stress
and childhood psychopathology in a large communi-
ty sample, Acta Psychiatr. Scand., 133, 122-132, https://
doi.org/10.1111/acps.12453.
55. Masi,A., Quintana, D.S., Glozier,N., Lloyd, A.R., Hick-
ie, I. B., and Guastella, A. J. (2015) Cytokine aberra-
tions in autism spectrum disorder: a systematic re-
view and meta-analysis, Mol. Psychiatry, 20, 440-446,
https://doi.org/10.1038/mp.2014.59.
56. Tokac, D., Tuzun, E., Gulec, H., Yılmaz, V., Bireller,
E. S., Cakmakoglu, B., and Kucukali, C. I. (2016)
Chemokine and Chemokine receptor polymorphisms
in bipolar disorder, Psychiatry Invest., 13, 541, https://
doi.org/10.4306/pi.2016.13.5.541.
57. Ho, P.-S., Yen, C.-H., Chen, C.-Y., Huang, S.-Y., and Liang,
C.-S. (2017) Changes in cytokine and chemokine ex-
pression distinguish dysthymic disorder from major
depression and healthy controls, Psychiatry Res., 248,
20-27, https://doi.org/10.1016/j.psychres.2016.12.014.
58. Fontenelle, L. F., Barbosa, I. G., Luna, J.V., de Sousa,
L. P., Abreu, M.N. S., and Teixeira, A.L. (2012) Acy-
tokine study of adult patients with obsessive-compul-
sive disorder, Comprehensive Psychiatry, 53, 797-804,
https://doi.org/10.1016/j.comppsych.2011.12.007.
59. García-Marchena,N., Araos, P.F., Barrios,V., Sánchez-
Marín,L., Chowen, J.A., Pedraz,M., Castilla-Ortega,E.,
Romero-Sanchiz,P., Ponce,G., Gavito, A.L., Decara,J.,
Silva, D., Torrens, M., Argente, J., Rubio, G., Serra-
no,A., de Fonseca, F.R., and Pavón, F.J. (2017) Plasma
chemokines in patients with alcohol use disorders:
association of CCL11 (eotaxin-1) with psychiatric co-
morbidity, Front. Psychiatry, 7, 214, https://doi.org/
10.3389/fpsyt.2016.00214.
60. Kuo, H.-W., Liu, T.-H., Tsou, H.-H., Hsu, Y.-T., Wang,
S.-C., Fang, C.-P., Liu, C.-C., Chen, A. C. H., and Liu,
Y.-L. (2018) Inflammatory chemokine eotaxin-1 is
correlated with age in heroin dependent patients
under methadone maintenance therapy, Drug Al-
cohol Depend., 183, 19-24, https://doi.org/10.1016/
j.drugalcdep.2017.10.014.
61. Panizzutti, B., Gubert, C., Schuh, A. L., Ferrari, P.,
Bristot, G., Fries, G. R., Massuda, R., Walz, J., Rocha,
N.P., Berk,M., Teixeira, A.L., and Gama, C. S. (2015)
Increased serum levels of eotaxin/CCL11 in late-stage
patients with bipolar disorder: an accelerated ag-
ing biomarker? J. Affect. Disord., 182, 64-69, https://
doi.org/10.1016/j.jad.2014.12.010.
62. Kim, K.-W., Vallon-Eberhard, A., Zigmond, E.,
Farache,J., Shezen, E., Shakhar, G., Ludwig, A., Lira,
S. A., and Jung, S. (2011) In vivo structure/function
and expression analysis of the CX3C chemokine frac-
talkine, Blood, 118, e156-e167, https://doi.org/10.1182/
blood-2011-04-348946.
63. Vukovic,J., Colditz, M.J., Blackmore, D.G., Ruitenberg,
M. J., and Bartlett, P. F. (2012) Microglia modulate